201. Factor V Leiden in pregnancies complicated by placental abruption.
- Author
-
Procházka M, Happach C, Marsál K, Dahlbäck B, and Lindqvist PG
- Subjects
- Activated Protein C Resistance genetics, Adult, Case-Control Studies, Female, Humans, Pregnancy, Pregnancy Complications, Hematologic etiology, Recurrence, Retrospective Studies, Thrombosis genetics, Abruptio Placentae genetics, Factor V genetics
- Abstract
Objective: Recent studies suggest an increased prevalence of obstetric complications in female carriers of hereditary or acquired thrombophilias. The aim of the study was to determine if carriership of the factor V (FV) Leiden mutation (activated protein C [APC] resistance) is higher in women who have had of placental abruption during pregnancy., Design: A retrospective case-control study., Setting: University Hospital MAS, Malmö, Sweden., Methods: A comparison of 102 women with placental abruption with 2371 prospectively collected controls. Carriership of FV Leiden was determined and the women were interviewed., Main Outcome Measures: Proportion of FV Leiden carriership, first degree heritage of thrombosis and previous placental abruption in cases and controls., Results: Carriage of FV Leiden was found in 15.7% of women who have had placental abruption as compared with 10.8% of controls (P = 0.12, odds ratio [OR] = 1.5, 95% confidence interval [CI] = 0.9-2.7). Around 20% of women with placental abruption reported first degree heritage for venous thrombosis, as compared with 6.7% of controls (P < or = 0.001)., Conclusions: FV Leiden carriership was not significantly different in women with placental abruption. However, there was an increased prevalence of first degree heritage for venous thrombosis in women with placental abruption, indicating a higher prevalence of thrombophilia among women with placental abruption.
- Published
- 2003